Exhibit 99.2

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data, unaudited)

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2006		2005		2006			2005
Revenue :
Services	$	274,158	$	237,198	$	792,509		$	690,615
Products		25,574		23,824		76,048			72,096
Total revenue		299,732		261,022		868,557			762,711
Cost of operations :
Services		158,967		142,484		472,951			414,533
Products		10,743		9,582		32,974			30,562
Total cost of operations		169,710		152,066		505,925			445,095
Development and engineering		9,243		8,912		27,164			26,595
Sales, marketing, general and administrative		74,050		63,865		216,263			189,292
Depreciation and amortization		18,189		15,801		51,964			44,826
Legal expense		1,023		5,904		1,840			14,347
Advisory expense		2,126		—		4,198			—
Loss on investments		—		—		—			3,642
Loss on redemption of convertible debt		—		—		—			1,902
Interest income		6,599		5,124		15,450			13,380
Interest expense		4,723		2,996		14,082			11,670
Other expense		—		1,863		—			1,863
Income from continuing operations before income tax provision and minority interest		27,267		14,739		62,571			36,859
Income tax provision		3,474		1,851		12,082			3,567
Minority interest in WebMD Health Corp., net of tax		140		38		(653	)		38
Income from continuing operations		23,653		12,850		51,142			33,254
Income from discontinued operations, net of tax		358,048		1,257		370,171			6,868
Net income	$	381,701	$	14,107	$	421,313		$	40,122
Basic income per common share:
Income from continuing operations	$	0.08	$	0.04	$	0.18		$	0.10
Income from discontinued operations		1.25		—		1.29			0.02
Net income	$	1.33	$	0.04	$	1.47		$	0.12
Diluted income per common share:
Income from continuing operations	$	0.08	$	0.03	$	0.17		$	0.09
Income from discontinued operations		1.19		0.01		1.25			0.02
Net income	$	1.27	$	0.04	$	1.42		$	0.11
Weighted-average shares outstanding used in computing income per common share:
Basic		287,967		356,091		286,749			339,576
Diluted		300,012		370,313		297,409			351,875

EMDEON CORPORATION
CONSOLIDATED SEGMENT INFORMATION
(In thousands, except per share data, unaudited)

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2006			2005			2006			2005
Revenue
Emdeon Business Services	$	187,266		$	171,396		$	557,974		$	516,941
WebMD		66,645			45,094			173,308			119,134
ViPS		24,843			24,278			73,525			66,310
Porex		21,298			20,410			64,544			60,663
Inter-segment eliminations		(320	)		(156	)		(794	)		(337	)
	$	299,732		$	261,022		$	868,557		$	762,711
Earnings before interest, taxes, non-cash and other items (“Adjusted EBITDA”)
Emdeon Business Services	$	44,547		$	32,297		$	127,519		$	103,315
WebMD		14,633			9,077			30,759			15,100
ViPS		5,302			3,988			15,517			11,992
Porex		6,133			6,385			18,732			17,846
Corporate		(11,000	)		(12,509	)		(33,633	)		(35,894	)
	$	59,615		$	39,238		$	158,894		$	112,359
Adjusted EBITDA per diluted common share (a)	$	0.20		$	0.11		$	0.53		$	0.32
Interest, taxes, non-cash and other items (b)
Depreciation and amortization	$	(18,189	)	$	(15,801	)	$	(51,964	)	$	(44,826	)
Non-cash stock-based compensation		(11,226	)		(1,073	)		(35,235	)		(3,631	)
Non-cash advertising		(1,660	)		(1,986	)		(4,454	)		(6,999	)
Legal expense		(1,023	)		(5,904	)		(1,840	)		(14,347	)
Advisory expense		(2,126	)		—			(4,198	)		—
Interest income		6,599			5,124			15,450			13,380
Interest expense		(4,723	)		(2,996	)		(14,082	)		(11,670	)
Income tax provision		(3,474	)		(1,851	)		(12,082	)		(3,567	)
Minority interest in WebMD Health Corp., net of tax		(140	)		(38	)		653			(38	)
Loss on investments		—			—			—			(3,642	)
Loss on redemption of convertible debt		—			—			—			(1,902	)
Other expense		—			(1,863	)		—			(1,863	)
Income from continuing operations		23,653			12,850			51,142			33,254
Income from discontinued operations, net of tax		358,048			1,257			370,171			6,868
Net income	$	381,701		$	14,107		$	421,313		$	40,122
Basic income per common share:
Income from continuing operations	$	0.08		$	0.04		$	0.18		$	0.10
Income from discontinued operations		1.25			—			1.29			0.02
Net income	$	1.33		$	0.04		$	1.47		$	0.12
Diluted income per common share:
Income from continuing operations	$	0.08		$	0.03		$	0.17		$	0.09
Income from discontinued operations		1.19			0.01			1.25			0.02
Net income	$	1.27		$	0.04		$	1.42		$	0.11
Weighted-average shares outstanding used in computing income per common share:
Basic		287,967			356,091			286,749			339,576
Diluted		300,012			370,313			297,409			351,875

(a)	Adjusted EBITDA per diluted common share is based on the weighted-average shares outstanding used in computing diluted income per common share.
(b)	Reconciliation of Adjusted EBITDA to net income (see Annex A — Explanation of Non-GAAP Financial Measures).

EMDEON CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, unaudited)

	September 30,		December 31,
	2006		2005
Assets
Cash and cash equivalents	$	875,460	$	155,616
Short-term investments		71,943		267,387
Accounts receivable, net		101,217		195,317
Inventory		9,342		10,791
Prepaid expenses and other current assets		39,889		30,936
Assets held for sale		949,693		—
Assets of discontinued operations		—		254,247
Total current assets		2,047,544		914,294
Marketable equity securities		2,668		4,430
Property and equipment, net		66,907		95,686
Goodwill		288,109		895,975
Intangible assets, net		125,969		235,271
Other assets		68,667		50,027
Total Assets	$	2,599,864	$	2,195,683
Liabilities and Stockholders’ Equity
Accounts payable	$	7,014	$	7,739
Accrued expenses		98,745		170,102
Deferred revenue		76,515		68,390
Liabilities held for sale		85,591		—
Liabilities of discontinued operations		—		68,436
Total current liabilities		267,865		314,667
Convertible notes		650,000		650,000
Other long-term liabilities		14,331		14,518
Minority interest in WebMD Health Corp.		60,413		43,229
Convertible redeemable exchangeable preferred stock		98,709		98,533
Stockholders’ equity		1,508,546		1,074,736
Total Liabilities and Stockholders’ Equity	$	2,599,864	$	2,195,683

EMDEON CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands, unaudited)

	Nine Months Ended
	September 30,
	2006			2005
Cash flows from operating activities:
Net income	$	421,313		$	40,122
Adjustments to reconcile net income to net cash provided by operating activities:
Income from discontinued operations, net of tax		(370,171	)		(6,868	)
Depreciation and amortization		51,964			44,826
Minority interest in WebMD Health Corp., net of tax		(653	)		38
Amortization of debt issuance costs		2,190			1,856
Non-cash advertising		4,454			6,999
Non-cash stock-based compensation		35,235			3,631
Bad debt expense		1,170			1,532
Loss on investments		—			3,642
Loss on redemption of convertible debt		—			1,902
Reversal of income tax valuation allowance applied to goodwill		5,307			4,330
Changes in operating assets and liabilities:
Accounts receivable		(19,930	)		(30,441	)
Inventory		601			472
Prepaid expenses and other, net		(9,701	)		(2,399	)
Accounts payable		825			(6,147	)
Accrued expenses and other long-term liabilities		3,284			10,710
Deferred revenue		9,926			9,430
Net cash provided by continuing operations		135,814			83,635
Net cash provided by discontinued operations		25,985			15,466
Net cash provided by operating activities		161,799			99,101
Cash flows from investing activities:
Proceeds from maturities and sales of available-for-sale securities		831,145			336,014
Purchases of available-for-sale securities		(632,955	)		(516,109	)
Purchases of property and equipment		(38,231	)		(39,107	)
Proceeds received from sale of discontinued operations		524,245			—
Cash paid in business combinations, net of cash acquired		(119,635	)		(74,380	)
Other changes in equity of discontinued operations		28,279			9,116
Net cash provided by (used in) continuing operations		592,848			(284,466	)
Net cash used in discontinued operations		(26,010	)		(18,964	)
Net cash provided by (used in) investing activities		566,838			(303,430	)
Cash flows from financing activities:
Proceeds from issuance of common stock		62,768			43,384
Purchases of treasury stock		(71,843	)		(4,596	)
Net proceeds from issuance of convertible debt		—			289,875
Redemption of convertible debt		—			(86,694	)
Payments of notes payable and other		(359	)		(495	)
Net cash (used in) provided by continuing operations		(9,434	)		241,474
Net cash (used in) provided by discontinued operations		—			—
Net cash (used in) provided by financing activities		(9,434	)		241,474
Effect of exchange rates on cash		616			(1,117	)
Net increase in cash and cash equivalents		719,819			36,028
Change in cash attributable to discontinued operations		25			3,498
Cash and cash equivalents at beginning of period		155,616			39,980
Cash and cash equivalents at end of period	$	875,460		$	79,506